Yogita Kanan

Title: Innovations in Retinal Disease Treatment by Yogita Kanan

Introduction

Yogita Kanan is an accomplished inventor based in Baltimore, MD (US). She has made significant contributions to the field of ophthalmology, particularly in the treatment of retinal diseases. With a focus on innovative methods, her work aims to improve the quality of life for individuals suffering from ocular diseases.

Latest Patents

Yogita Kanan holds a patent for "Methods of treating retinal diseases." This patent describes a method of treating or inhibiting degeneration of the retina in subjects in need. The method involves administering an effective amount of metipranolol or its metabolites to the affected organ or tissue. The administration can be done topically, orally, or parenterally, with specific dosages ranging from 0.5 µg/day to 15 µg/day. This innovative approach has the potential to significantly impact the treatment of retinal degeneration caused by various ocular diseases.

Career Highlights

Throughout her career, Yogita has worked with notable organizations such as Alimera Sciences, Inc. and The Johns Hopkins University. Her experience in these institutions has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Yogita has had the opportunity to work alongside esteemed colleagues, including Kenneth E Green and Peter Anthony Campochiaro. These collaborations have further enriched her research and development efforts in the treatment of retinal diseases.

Conclusion

Yogita Kanan's innovative work in the treatment of retinal diseases showcases her dedication to advancing medical science. Her patent and collaborations highlight her significant contributions to the field, making her a prominent figure in ophthalmology.